---
category: news
title: "Pluristem joins CRISPR-IL to develop next-gen genome editing products"
excerpt: "We see cell therapy and gene editing as highly synergistic methods to treat and cure diseases using advanced technologies,‚Äù said Pluristem CEO Yaky Yanay."
publishedDateTime: 2020-06-04T15:00:00Z
webUrl: "https://www.jpost.com/health-science/pluristem-joins-crispr-il-to-develop-next-gen-genome-editing-products-630337"
ampWebUrl: "https://m.jpost.com/health-science/pluristem-joins-crispr-il-to-develop-next-gen-genome-editing-products-630337/amp"
cdnAmpWebUrl: "https://m-jpost-com.cdn.ampproject.org/c/s/m.jpost.com/health-science/pluristem-joins-crispr-il-to-develop-next-gen-genome-editing-products-630337/amp"
type: article
quality: 44
heat: 44
published: false

provider:
  name: The Jerusalem Post Blogs
  domain: jpost.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://images.jpost.com/image/upload/f_auto,fl_lossy/t_JM_ArticleMainImageFaceDetect/445027"
    width: 640
    height: 428
    isCached: true
    title: "Pluristem joins CRISPR-IL to develop next-gen genome editing products"

secured: "uY6OTwXsyr8j8q9xZabDNbM1jSE7letIF0abLtjwYn6J1f2T5xSu5E6SIGgyOOC+Alejwgldy4droJudOru/Lod1G54EW+oyeyAd9NU99VDD6ka6DJZU5GhknLGf+p7csCRgXOv3XI7uizex5Dg9iaiLJzTHLO3uuM3Izo8Y2JPoHXCMDG71M4X/oY+eAzMDoOf7YgA991oMqsQ6IrTiQslUJa596td2YbOjFIwudBoKoI5DyQuZ/PFC3OjqcOuh29Yo7umUSaNzA0xgXsVd7sZY1G060GLoJ5pPTPtQBW13MflVmyayg9vEIqjXbA2wwutIKZWqal9A/iQiKwjPbS+boXYtWa+ur2f5rv4zOnvXCzO+eBGWm4Vz4veDvJ8wsGuuUzpmjG6POytjVEabvK5tAt3yrDNcgwR90VlwE5dVXnWqkFmJJAXrV+5LFAXHcc/4ZudunL9YekARCNexl6CjVKBWxTmd1AJjtY/3Oqc=;ybFbkHbTX3m/vkN/556t7g=="
---

